Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding is a research paper published in Cancer Discovery (2025). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Sussman Family Fund
Grant: Sussman Family Fund
Breast Cancer Research Foundation
Grant: BCRF-24-185
Center for Cancer Research
Grant: P30 CA008748
National Institute of Mental Health
Grant: P50 CA247749-01
National Institutes of Health
Grant: 1R01CA249666-01A
National Institutes of Health
Grant: P30 CA008748 S5
U.S. Food and Drug Administration
Grant: 1U01FD007909-01A1
NCI NIH HHS
Grant: R01 CA249666
FDA HHS
Grant: U01 FD007909
NCI NIH HHS
Grant: R35 CA305347
NCI NIH HHS
Grant: P50 CA247749
NCI NIH HHS
Grant: K99 CA286801
FWCI
13.35
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords